Literature DB >> 9720319

Stability of a highly charged noncovalent complex in the gas phase: holomyoglobin.

Y L Chen1, J M Campbell, B A Collings, L Konermann, D J Douglas.   

Abstract

Gas phase holomyoglobin (hMb) ions in charge states +7 to +21 were formed by electrospray ionization in combination with a continuous-flow mixing apparatus. Collision cross section measurements show that the highly charged ions are somewhat unfolded in comparison to low charge states but still retain a considerable degree of folding. A new collision model is presented which calculates the relative energies transferred to complexes in tandem mass spectrometry. Tandem mass spectrometry and ion trapping experiments both show that the energies required to dissociate heme from the highly charged heme-protein complexes in the gas phase are similar to those of low charge states, previously shown in literature ion cyclotron resonance experiments to be 0.7-1.0 eV. These energies are comparable to those of the heme binding energy in solution. The results suggest that even for the highly charged hMb ions which have unfolded somewhat, the heme-protein interactions remain relatively unperturbed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720319     DOI: 10.1002/(SICI)1097-0231(19980815)12:15<1003::AID-RCM275>3.0.CO;2-#

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  15 in total

1.  Effects of pH on the kinetic reaction mechanism of myoglobin unfolding studied by time-resolved electrospray ionization mass spectrometry.

Authors:  O O Sogbein; D A Simmons; L Konermann
Journal:  J Am Soc Mass Spectrom       Date:  2000-04       Impact factor: 3.109

2.  Investigation of bovine ubiquitin conformers separated by high-field asymmetric waveform ion mobility spectrometry: cross section measurements using energy-loss experiments with a triple quadrupole mass spectrometer.

Authors:  R W Purves; D A Barnett; B Ells; R Guevremont
Journal:  J Am Soc Mass Spectrom       Date:  2000-08       Impact factor: 3.109

3.  Tandem mass spectrometry of protein-protein complexes: cytochrome c-cytochrome b5.

Authors:  M R Mauk; A G Mauk; Yu-Luan Chen; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2002-01       Impact factor: 3.109

4.  Further studies on the origins of asymmetric charge partitioning in protein homodimers.

Authors:  John C Jurchen; David E Garcia; Evan R Williams
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

5.  Gas-phase ions of human hemoglobin A, F, and S.

Authors:  Yang Kang; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-19       Impact factor: 3.109

6.  Heme binding in gas-phase holo-myoglobin cations: distal becomes proximal?

Authors:  Atim A Enyenihi; Hongqian Yang; A Jimmy Ytterberg; Yaroslav Lyutvinskiy; Roman A Zubarev
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-19       Impact factor: 3.109

7.  Peptide conformation in gas phase probed by collision-induced dissociation and its correlation to conformation in condensed phases.

Authors:  Zhongqi Zhang; Joseph Bordas-Nagy
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-03       Impact factor: 3.109

8.  Conformations of gas-phase ions of ubiquitin, cytochrome c, apomyoglobin, and beta-lactoglobulin produced from two different solution conformations.

Authors:  P John Wright; Jianmin Zhang; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-24       Impact factor: 3.109

9.  Erratum to: Axial imidazole binding strengths in porphyrinoid cobalt(III) complexes as studied by tandem mass spectrometry.

Authors:  Ekta Mishra; Jill L Worlinsky; Thomas M Gilbert; Christian Brückner; Victor Ryzhov
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-12       Impact factor: 3.109

10.  The effect of a covalent and a noncovalent small-molecule inhibitor on the structure of Abg β-glucosidase in the gas-phase.

Authors:  Khadijeh Rajabi; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2013-04-18       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.